Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/37290
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA) but not 3 4-methylenedioxymethamphetamine (MDMA) leads to long-lasting deficits in serotonin transporter function
Author: Callaghan, P.
Owens, W.
Javors, M.
Sanchez, T.
Jones, D.
Irvine, R.
Daws, L.
Citation: Journal of Neurochemistry, 2007; 100(3):617-627
Publisher: Blackwell Publishing Ltd
Issue Date: 2007
ISSN: 0022-3042
1471-4159
Statement of
Responsibility: 
Paul D. Callaghan, W. Anthony Owens, Martin A. Javors, Teresa A. Sanchez, David J. Jones, Rodney J. Irvine and Lynette C. Daws
Abstract: p-Methoxyamphetamine (PMA) has been implicated in fatalities as a result of ‘ecstasy’ (MDMA) overdose worldwide. Like MDMA, acute effects are associated with marked changes in serotonergic neurotransmission, but the long-term effects of PMA are poorly understood. The aim of this study was to determine the effect of repeated PMA administration on in vitro measures of neurodegeneration: serotonin (5-HT) uptake, 5-HT transporter (SERT) density and 5-HT content in the hippocampus, and compare with effects on in vivo 5-HT clearance. Male rats received PMA, MDMA (4 or 15 mg/kg s.c., twice daily) or vehicle for 4 days and 2 weeks later indices of SERT function were measured. [3H]5-HT uptake into synaptosomes and [3H]cyanoimipramine binding to the SERT were significantly reduced by both PMA and MDMA treatments. 5-HT content was reduced in MDMA-, but not PMA-treatment. In contrast, clearance of locally applied 5-HT measured in vivo by chronoamperometry was only reduced in rats treated with 15 mg/kg PMA. The finding that 5-HT clearance in vivo was unaltered by MDMA treatment suggests that in vitro measures of 5-HT axonal degeneration do not necessarily predict potential compensatory mechanisms that maintain SERT function under basal conditions.
Keywords: chronoamperometry; 3, 4-methylenedioxymethamphetamine; neurodegeneration; para-methoxyamphetamine; serotonin; serotonin transporter
RMID: 0020070081
DOI: 10.1111/j.1471-4159.2006.04247.x
Published version: http://www.blackwell-synergy.com/doi/abs/10.1111/j.1471-4159.2006.04247.x
Appears in Collections:Pharmacology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.